Method of producing insulinotropic GLP-1 (7-36) polypeptide and/or GLP-1 analogs
    1.
    发明授权
    Method of producing insulinotropic GLP-1 (7-36) polypeptide and/or GLP-1 analogs 有权
    产生促胰岛素GLP-1(7-36)多肽和/或GLP-1类似物的方法

    公开(公告)号:US07544512B2

    公开(公告)日:2009-06-09

    申请号:US10761717

    申请日:2004-01-20

    CPC classification number: C07K14/605 C07K2319/00

    Abstract: The present invention discloses a method of producing polypeptides, including insulinotropic GLP-1 (7-36) polypeptide and/or GLP-1 analogs, by ligating genes in a tandem way. Also disclosed are the recombinant polypeptides produced by such a method. Using the method of this invention, 1 to 32 copies of GLP-1 (7-36) and/or GLP-1 analog genes may be expressed in tandem and the desired polypeptide can be obtained after cleavage of a fusion protein and further processes of separation and purification thus making possible the production of recombinant polypeptides, including recombinant GLP-1 (7-36) and/or GLP-1 analogs on a large scale, at a significantly reduced production cost.

    Abstract translation: 本发明公开了通过以串联方式连接基因来产生包括促胰岛素GLP-1(7-36)多肽和/或GLP-1类似物的多肽的方法。 还公开了通过这种方法产生的重组多肽。 使用本发明的方法,可以串联表达1至32拷贝的GLP-1(7-36)和/或GLP-1类似物,并且可以在切割融合蛋白后获得所需的多肽, 分离和纯化,从而以显着降低的生产成本使得大规模生产重组多肽(包括重组GLP-1(7-36)和/或GLP-1类似物)成为可能。

Patent Agency Ranking